Therefore, relating the embryonic expression of NRs, including classical pharmacological targets like TR, RAR, RXR, and PXR, to specific developmental processes will help to better understand the mechanisms of the development of metabolic syndrome. Here, NR1I2 is linked to metabolic syndrome.